Misplaced Pages

#302697

46-418: The aortic valve normally has three cusps however there is some discrepancy in their naming. They may be called the left coronary, right coronary and non-coronary cusp. Some sources also advocate they be named as a left, right and posterior cusp. Anatomists have traditionally named them the left posterior (origin of left coronary), anterior (origin of the right coronary) and right posterior. The three cusps, when

92-463: A cadaver) or a valvular prothesis is then used to replace the patient's own pulmonary valve. The first minimally invasive aortic valve surgery took place at the Cleveland Clinic in 1996. Endocarditis is infection of the heart and this often results in vegetations growing on valves. While it is possible for it to affect the aortic valve, it is not the most likely spot . Evaluation of

138-528: A higher rate of NSVD. In elderly patients the prostheses should outlive the patient. The 2021 review suggested that in younger patients (with longer average life expectancy) choosing TAVI might still be premature, due to the increased likelihood of the need for future re-operation with worse prognostic impact. The catheter procedure was invented and developed in Aarhus University Hospital Denmark in 1989 by Henning Rud Andersen, who performed

184-422: A mortality rate of approximately 50% at 2 years without intervention. In patients who are deemed too high risk for open heart surgery, TAVI significantly reduces the rates of death and cardiac symptoms. Until about 2017 TAVI was not routinely recommended for low-risk patients in favor of aortic valve replacement, however it is increasingly being offered to intermediate risk patients, based on studies finding that it

230-713: A poor prognosis. At present, there is no treatment via medication, making the timing of aortic valve replacement the most important decision to make for these patients. Until recently, surgical aortic valve replacement was the standard treatment for adults with severe symptomatic aortic stenosis. However, the risks associated with surgical aortic valve replacement are increased in elderly patients and those with concomitant severe systolic heart failure or coronary artery disease , as well as in people with comorbidities such as cerebrovascular and peripheral arterial disease , chronic kidney disease , and chronic respiratory dysfunction. Patients with symptomatic severe aortic stenosis have

276-440: A smaller number of patients who are not eligible for transfemoral, transapical, or transaortic approaches. In the transcaval approach a tube is inserted via the femoral vein instead of the femoral artery, and a small wire is used to cross from the inferior vena cava into the adjacent abdominal aorta. Once the wire is across, a large tube is used to place the transcatheter heart valve through the femoral vein and inferior vena cava into

322-412: A transapical TAVI procedure found that participants felt weak and tired at first after TAVI, some more than before the procedure. Some reported a later "surprisingly simple rehabilitation" with rapid recovery, while others had a "demanding rehabilitation", with slow recovery, fatigue, and weakness. The durability of transcatheter prostheses, in terms of all-cause mortality and the need of re-intervention,

368-399: Is a type of surgical procedure when the aortic valve, aortic root, and ascending aorta are replaced in a single operation. There are two basic types of artificial heart valve : mechanical and tissue. There are alternatives to animal tissue valves. In some cases, a human aortic valve can be implanted. These are called homografts . Homograft valves are donated by patients and recovered after

414-446: Is an alternative. The transfemoral approach requires the catheter and valve to be inserted via the femoral artery. Similar to coronary artery stenting procedures, this is accessed via a small incision in the groin, through which the delivery system is slowly fed along the artery to the correct position at the aortic valve. A larger incision in the groin may be required in some circumstances. The femoral artery (via transfemoral approach)

460-403: Is delivered via one of several access methods: transfemoral (in the upper leg), transapical (through the wall of the heart), subclavian (beneath the collar bone), direct aortic (through a minimally invasive surgical incision into the aorta), and transcaval (from a temporary hole in the aorta near the navel through a vein in the upper leg), among others. Severe symptomatic aortic stenosis carries

506-498: Is incomplete sealing between the native heart valve and the stented valve, paravalvular leak (PVL) can occur. Key properties associated with paravalvular leak are the regurgitation volume, the PVL orifice location (anterior or posterior) and the associated fluid dynamic effects that occur from the interactions between the regurgitated flow and the normal transmitral flow. Morisawa et al. carried out quantitative research to determine how

SECTION 10

#1732883476303

552-421: Is less often used for aortic stenosis & insufficiency because the angle between the probe and the aortic valve is not optimal (the best window is a transgastric view). MRI and CT can be used to evaluate the valve, but much less commonly than TTE. Quantification of the maximum velocity through the valve, the area of the opening of the valve, calcification, morphology (tricuspid, bicuspid, unicuspid), and size of

598-551: Is not inferior to surgical aortic valve replacement. Transapical TAVI is reserved for patients for whom other approaches are not feasible: an evidence-based BMJ Rapid Recommendation made a strong recommendation against transapical TAVI in people who are also candidates for either transfemoral TAVI or surgery. People who have the option of either transfemoral TAVI or surgical replacement are likely to choose surgery if they are younger than 75 and transfemoral TAVI if they are older than 75. The rationale for age-based recommendations

644-531: Is presently unclear. Within 24 hours post-operation, patients are encouraged to be walking. It is common for patients to have an overnight hospital stay post operatively. Follow-up examinations (Chest X-ray, EKG, and Cardiac US) ensure heart functioning. Incision sites are monitored closely. Pts. are encouraged not to drive for 72 hours post operatively, and to avoid physical activity for up to 10 days. Most patients resume activity within 2 weeks. A 2018 study that interviewed nineteen elderly patients six months after

690-528: Is repositionable before release to ensure accurate placement helping to improve patient outcomes. Edwards ' Sapien aortic valve is made from bovine pericardial tissue and is implanted via a catheter -based delivery system. It is approved by the FDA for use in the US. The devices are implanted without open heart surgery. The valve delivery system is inserted in the body, the valve is positioned and then implanted inside

736-533: Is that surgical aortic valve replacements are known to be durable long-term (average of durability of 20 years), so people with longer life expectancy would be at higher risk if TAVI durability is worse than surgery. Medtronic 's CoreValve Transcatheter Aortic Valve is constructed of a self-expanding Nitinol (nickel titanium) frame and delivered through the femoral artery . This device received FDA approval in January 2014. Boston Scientific 's Lotus Valve system

782-477: Is the implantation of the aortic valve of the heart through the blood vessels without actual removal of the native valve (as opposed to the aortic valve replacement by open heart surgery , surgical aortic valve replacement , AVR). The first TAVI was performed on 16 April 2002 by Alain Cribier , which became a new alternative in the management of high-risk patients with severe aortic stenosis. The implantated valve

828-413: Is the traditional access for percutaneous aortic valve implantation. The transapical approach sees the catheter and valve inserted through the tip of the heart and into the left ventricle. Under general anesthesia, a small surgical incision is made between the ribs, followed by a small puncture of the heart. The delivery system is then fed slowly to the correct position at the aortic valve. The puncture in

874-626: Is then removed and the incision is sutured closed. Regular medical checkups and imaging tests are required after TAVI. The Mayo Clinic says that blood thinners ( anticoagulants ) are prescribed to prevent blood clots after TAVI. Artificial heart valves are susceptible to bacterial infection; most bacteria that cause heart valve infections come from the mouth, so that good dental hygiene and routine dental cleaning are recommended. Antibiotics are prescribed for use before certain dental procedures. New or worse post-procedure symptoms that require attention include dizziness or light-headedness, swelling of

920-523: The ascending aorta , which occurs just above the aortic valve . These widenings are between the wall of the aorta and each of the three cusps of the aortic valve. The aortic sinuses cause eddies which prevent the valve cusps from touching the internal surface of the aorta and obstructing the openings of the coronary arteries. There are generally three aortic sinuses, one anterior and two posterior sinuses. These give rise to coronary arteries : The aortic sinuses are typically more prominent than

966-460: The "Big 5 of TAVI complications" include paravalvular leakage (PVL), major bleeding or vascular complications, acute kidney injury (AKI), stroke, and conduction abnormalities, such as high-degree AV-block with need for permanent pacemaker implantation must be monitored to ensure successful procedural outcomes such as low mortality and morbidity. There is a ~3% risk of stroke associated with TAVI due to embolism or altered hemodynamics during or after

SECTION 20

#1732883476303

1012-479: The PVL flow effected normal transmitral flow based on three different in-vitro situations: no PVL, anterior orifice PVL and posterior orifice PVL. The results showed that while the two PVL cases worsened the fluid dynamics of the normal transmitral flow seen without leakage, the posterior orifice PVL was worse, leading to a higher circulation and kinetic energy, requiring the heart to work harder and consume more energy to maintain normal bodily functions. Additionally,

1058-425: The ankles, sudden weight gain, extreme fatigue with activity, and signs of infection. Emergency attention is required for chest pain, pressure or tightness, severe, sudden shortness of breath, or fainting. When PAVR surgery is performed an important and difficult aspect that affects the patient is the orientation, uniformity and depth at which the valve is inserted. When the valve is not inserted correctly, when there

1104-411: The aorta and from there the heart. This otherwise resembles the transfemoral approach. Afterwards, the hole in the aorta is closed with a self-collapsing nitinol device designed to close holes in the heart. In the subclavian approach, an incision is made under the collarbone under general anesthesia, and the delivery system is advanced into the correct position in the aortic valve. The delivery system

1150-477: The aorta, previous rheumatic fever , infection such as infective endocarditis , degeneration of the aortic valve, and Marfan's syndrome . Aortic stenosis can also be caused by rheumatic fever and degenerative calcification . The most common congenital heart defect is the bicuspid aortic valve (fusion of two cusps together) commonly found in Turner syndrome . Once diagnosed, the two options are to repair or replace

1196-450: The aorta. When ventricular systole ends, pressure in the left ventricle rapidly drops. When the pressure in the left ventricle decreases, the momentum of the vortex at the outlet of the valve forces the aortic valve to close. The closure of the aortic valve contributes the A 2 component of the second heart sound (S 2 ). Closure of the aortic valve permits maintaining high pressures in the systemic circulation while reducing pressure in

1242-442: The aortic valve can be done with several modalities. Auscultation with a stethoscope is quick and easy. It contributes the A 2 component to the second heart sound and changes with inspiration ("splitting") Transthoracic echocardiography (TTE) is used as the first test because it is non-invasive. Using TTE, the degree of stenosis and insufficiency can be quantified to grade the valve dysfunction. Transesophageal echocardiography

1288-474: The diseased aortic valve, and then the delivery system is removed. The catheter-based delivery system can be inserted into the body from one of several sites. Pre-procedural planning includes aortic valve annulus measurements and possible procedural complication likelihood. The standard for preoperative plans is to perform a multi-detector computed angiotomography (MDCT), which delivers the information required. Magnetic resonance imaging (MRI) and 3D echocardiography

1334-590: The first animal implantations that year. The first implantation in a human was performed on 16 April 2002 by Alain Cribier in Hopital Charles Nicolle, at the University of Rouen , France. Technology experts Stan Rowe and Stan Rabinowitz partnered with physicians Alain Cribier and Martin Leon of NewYork–Presbyterian Hospital and others to create the company Percutaneous Valve Technologies (PVT) in 2002. The company

1380-448: The heart is then sutured shut. The transaortic approach sees the catheter and valve inserted through the top of the right chest. Under general anesthesia, a small surgical incision is made alongside the right upper breastbone, followed by a small puncture of the aorta. The delivery system is then fed slowly to the correct position at the aortic valve. The hole in the aorta is then sutured shut. The transcaval approach has been applied to

1426-462: The heart. Consequently, heart failure and pulmonary edema can develop. Slowly worsening aortic insufficiency results in a chronic aortic regurgitation which permits the heart to compensate (unlike acute aortic regurgitataion). This compensation is through dilation of the left ventricle and return to normal filling pressures. Inadequate opening of the aortic valve, often through calcific aortic valve disease , results in higher flow velocities through

Aortic valve - Misplaced Pages Continue

1472-412: The left ventricle to permit blood flow from the lungs to fill the left ventricle. Abrupt loss of function of the aortic valve results in acute aortic regurgitation (also known as acute aortic insufficiency) and loss in the normal diastolic blood pressure resulting in a wide pulse pressure and bounding pulses. The endocardium perfuses during diastole and so acute aortic regurgitation can reduce perfusion of

1518-495: The native valve with a prosthetic valve. Traditionally, this has been a surgical procedure (surgical AVR or SAVR) but a non-surgical option called transcatheter aortic valve replacement (TAVR) or TAVI transcatheter aortic valve implantation delivers a prosthetic valve through a catheter . The choice between SAVR and TAVR often relies on the open-heart surgical risk and indications for other open heart surgeries (etc., coronary bypass, other valve dysfunction). The Bentall procedure

1564-405: The origins are in the sinuses facing the pulmonary valve. [REDACTED] The term "semilunar" refers to an approximate half-moon shape of the valve leaflets. When the left ventricle contracts ( systole ), pressure rises in the left ventricle. When the pressure in the left ventricle rises above the pressure in the aorta, the aortic valve opens, allowing blood to exit the left ventricle into

1610-460: The patient expires. The durability of homograft valves is probably the same as for porcine tissue valves. Another procedure for aortic valve replacement is the Ross procedure (after Donald Ross ) or pulmonary autograft . The Ross procedure involves going to surgery to have the aortic valve removed and replacing it with the patient's own pulmonary valve. A pulmonary homograft (a pulmonary valve taken from

1656-444: The procedure. Approximately 70% of patients undergoing TAVI show signs of clinically silent brain infarcts on neuroimaging afterwards. Further, levels of the neuroaxonal damage biomarker neurofilament light chain are elevated in blood plasma after TAVI. Whereas clinical stroke is associated with reduced quality of life and cognitive impairment, the significance of silent brain infarcts and elevated levels of neurofilament light

1702-501: The prosthetic valve structure), NSVD (non-structural valve deterioration, including irreversible intra- or para-prosthetic regurgitation, prosthesis malposition, and patient-prosthesis mismatch), valve thrombosis, and endocarditis (which can be potentially reversible). Durability seems to be similar between TAVI and surgical implantation (SAVR), but there is a lack of long-term data, with only computed simulation models available. In many respects TAVI and SAVR are comparable, but TAVI still has

1748-540: The pulmonary sinuses. If the coronary arteries arise from the wrong aortic sinuses, this can put the heart's ventricles at risk of ischaemia . This is often only discovered when a heart attack has already occurred, usually before the age of 20 and during exercise . Each aortic sinus can also be referred to as the sinus of Valsalva , the sinus of Morgagni , the sinus of Mehta , the sinus of Otto , or Petit's sinus . Percutaneous aortic valve replacement Transcatheter aortic valve replacement ( TAVR )

1794-399: The pulmonary valve and the commissure where the anterior two cusps join together points toward the pulmonary valve. It is these two sinuses that contain the origin of the coronary arteries. In the congenital disease known as transposition of the great arteries , these two valves are reversed (the anterior valve is the aortic valve) and the origin of the coronaries still follows this "rule" that

1840-400: The valve (annulus, sinuses, sinotubular junction) are common parameters when evaluating the aortic valve. Invasive measurement of the aortic valve can be done during a cardiac catheterization in which the pressure in the left ventricle and aorta can be measured simultaneously. Aortic sinus An aortic sinus , also known as a sinus of Valsalva , is one of the anatomic dilations of

1886-552: The valve and larger pressure gradients. Diagnosis of aortic stenosis is contingent upon quantification of this gradient. This condition also results in hypertrophy of the left ventricle. A normally functioning valve permits normal physiology and dysfunction of the valve results in left ventricular hypertrophy and heart failure. Dysfunctional aortic valves often present as heart failure by non-specific symptoms such as fatigue, low energy, and shortness of breath with exertion. Common causes of aortic regurgitation include vasodilation of

Aortic valve - Misplaced Pages Continue

1932-407: The valve is closed, contain a sinus called an aortic sinus or sinus of Valsalva. In two of these cusps, the origin of the coronary arteries are found. The width of the sinuses in cross-section is wider than the left ventricular outflow tract as well as wider than the ascending aorta. The junction of the sinuses with the aorta is called the sinotubular junction. The aortic valve is located posterior to

1978-411: The valve. Aortic valve repair or aortic valve reconstruction describes the reconstruction of both form and function of the native and dysfunctioning aortic valve. Most frequently it is applied for the treatment of aortic regurgitation. It can also become necessary for the treatment of aortic aneurysm, or less frequently for congenital aortic stenosis. Replacement of the aortic valve is done by replacing

2024-560: Was awarded CE approval in October 2013. It allows the final position to be assessed and evaluated before release and has been designed to minimise regurgitation. Boston Scientific has since retired the device as of January 11, 2021. This was primarily due to difficulty regarding the ability to reposition and recapture the valve. St Jude Medical 's Portico Transcatheter aortic valve received European CE mark approval in December 2013. The valve

2070-445: Was not reliably known as of 2021 due to the lack of long-term follow-up data. A narrative review published in 2021 reported that a 2015 study involving simulation on first-generation prostheses suggested a TAVI durability limited to 7–8 years. Later prostheses have improved durability. Bioprosthetic valve disfunction (BVD) has historically been divided into SVD (structural valve deterioration, including irreversible intrinsic changes of

2116-550: Was purchased by Edwards Lifesciences in 2004; its valve became the Sapien valve. It was the first aortic valve device to receive FDA approval, in November 2011 for use in inoperable patients and in October 2012 for use in patients at high surgical risk. The device is effective in improving functioning in patients with severe aortic stenosis. It is now approved in more than 50 countries. Internationally famous pop singer Mick Jagger had

#302697